Gustaf Mårtensson from MYCRONIC, explains in a video their role in the project as experts in optics, lasers and data handling. “By incorporating MYCRONIC’s lithographic semiconductor printing technology, we are able to manufacture cell-laden 3D constructs that resemble the complexity of human tissues”.
This video highlights the great opportunities of the 3D bioprinting technology to the biomedical field, concretely in the fabrication of human tissues that can be used for wound treating, drug testing and in the future, even for total organ replacement. Together with the other partners of BRIGHTER project, MYCRONIC develops a novel light-based patterning technology that can create this kind of tissues.
What MYCRONIC brings to BRIGHTER is a long experience in accurate acousto-optic patterning technology that can be combined with advanced cell laden bioinks that are light sensitive to be able to pattern very minor details down to the size of fan individual cell, in a quick and reliable way. MYCRONIC provides knowledge and manpower for system design, for pattern generators as well as for pattern generator optics, servo, data channel and system control software.
In a nutshell, they convert a three dimensional computer model of the biological tissue into a series of instructions for how to move a laser beam, and at the same time, control the light intensity of that laser beam, projected down to the size of a single human cell. One of the main advantages of this technology is that it’s highly scalable and cell friendly.
«I think it’s actually pretty amazing to take an existing technology that’s used in the world of electronics and transfer this to the realm of biology, where it has the opportunity to help so many people.»